Results 141 to 150 of about 5,030 (173)

Progressive multifocal leukoencephalopathy (PML)

2023
openaire   +1 more source

Polyomavirus-Associated Progressive Multifocal Leukoencephalopathy (PML) in HAART era

2016
Polyomaviruses may cause human disease, particularly in immunocompromised hosts. JCV, one of the members of polyomaviridae family, is the causative agent of the neurological disease progressive multifocal leukoencephalopathy (PML), which occurs mostly in immunocompromised patients.
openaire   +1 more source

Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy

Viruses, 2022
Irène Cortese, Steven Jacobson, Sanchita Das   +2 more
exaly  

CEREBELLAR FORM OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)

Journal of Neuropathology and Experimental Neurology, 1986
N. R. Ghatak, A. J. Aksamit, R. H. Pridgeon   +2 more
openaire   +1 more source

Progressive multifocal leukoencephalopathy (sarcoidosis associated PML)

2023
openaire   +1 more source

Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations

Clinical Neurology and Neurosurgery, 2012
Rudi Beschorner, T Nägele, U Ernemann   +2 more
exaly  

Progressive Multifocal Leukoencephalopathy (PML) in Two Cases of Cortical Blindness

AIDS Patient Care, 1994
D D, Smith, M R, Robinson, S F, Scheibel, W M, Valenti, T A, Eskin   +4 more
openaire   +2 more sources

A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes

Journal of NeuroVirology, 2013
David Clifford, Robert Zivadinov, Bruce Brew   +2 more
exaly  

Epidemiological features of progressive multifocal leukoencephalopathy (PML) in Japan

Journal of Neurovirology, 2004
H Mizusawa, S Kishida, Y Kuroda, Y Yogo, K Yasui, K Nagashima   +5 more
openaire   +1 more source

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

Multiple Sclerosis Journal, 2012
Gavin Giovannoni, Xavier Montalbán, Per Soelberg Sorensen   +2 more
exaly